Transcatheter Aortic Valve Implantation in Western NORway

NCT04417829 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2023-09-22

No results posted yet for this study

Summary

A prospective study of 600 patients with severe aortic stenosis (AS) and symptoms who underwent TAVI at the Haukeland university hospital, Bergen, Norway.

Conditions

Interventions

DEVICE

Biological prosthesis in the aortic valve

Transcatheter aortic valve implantation of bioprosthesis in patients with severe symptomatic aortic stenosis (clinically indicated)

Sponsors & Collaborators

  • Haukeland University Hospital

    lead OTHER

Principal Investigators

  • Sahrai Saeed, MD.Ph.D. · Department of Heart Disease Haukeland University Hospital, Begen, Norway

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2019-07-31
Completion
2019-07-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04417829 on ClinicalTrials.gov